Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Evaluation of CG-100 Intraluminal Bypass Device

NCT: NCT05632744 · COMPLETED

NCT IDNCT05632744
StatusCOMPLETED
Start Date2023-03-15
Completion2024-04-15
SponsorColospan Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

Evaluation of CG-100 Intraluminal Bypass device

Frequently Asked Questions

What is Evaluation of CG-100 Intraluminal Bypass Device?

Evaluation of CG-100 Intraluminal Bypass Device is a clinical trial registered under NCT05632744. Current status: COMPLETED.

What is the status of NCT05632744?

The current status of NCT05632744 (Evaluation of CG-100 Intraluminal Bypass Device) is: COMPLETED.

When did Evaluation of CG-100 Intraluminal Bypass Device start?

Evaluation of CG-100 Intraluminal Bypass Device started on 2023-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑